miR-192 inhibits the activation of hepatic stellate cells by targeting Rictor

The activation of hepatic stellate cells (HSCs) is regarded as the primary driving factor of liver fibrosis. miR-192, a miRNA associated with hepatocellular carcinoma and enriched in HSCs, has an undisclosed role in HSC activation and liver fibrosis. In this study, a CCl4-induced rat liver fibrosis...

Full description

Bibliographic Details
Published in:	Open Medicine
Main Authors:	Kang Hui, Luo Jie, Wang Chun, Hong Yinghui, Ye Mingliang, Ding Yang, Zhao Qiu, Chang Ying
Format:	Article
Language:	English
Published:	De Gruyter 2023-12-01
Subjects:	liver fibrosis microrna-192 rictor hepatic stellate cell smad
Online Access:	https://doi.org/10.1515/med-2023-0879

Similar Items

Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis
by: Chun Wang, et al.
Published: (2023-12-01)

miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis
by: Li Zhou, et al.
Published: (2018-03-01)

Activation of primary hepatic stellate cells and liver fibrosis induced by targeting TGF-β1/Smad signaling in schistosomiasis in mice
by: Ping Huang, et al.
Published: (2022-12-01)

Rictor Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Suppressing Autophagy and Regulating MAPK Signaling
by: Dongwei Xu, et al.
Published: (2018-03-01)

RANKL inhibits activation of hepatic stellate cells during hepatic fibrosis in mice
by: ZHOU Lijia, et al.
Published: (2023-01-01)

Layered Double Hydroxides-Loaded Sorafenib Inhibit Hepatic Stellate Cells Proliferation and Activation In Vitro and Reduce Fibrosis In Vivo
by: Wei Peng, et al.
Published: (2022-05-01)

mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
by: Dániel Sztankovics, et al.
Published: (2024-03-01)

Thymosin-β4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway
by: Lili Zhu, et al.
Published: (2018-11-01)

Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer
by: Xiongqun Peng, et al.
Published: (2023-09-01)

RICTOR amplification is associated with Rictor membrane staining and does not correlate with PD-L1 expression in lung squamous cell carcinoma
by: Ildikó Krencz, et al.
Published: (2024-04-01)

Elevated miR-34a induced by lipotoxicity and inflammation mediates pathophysiological communication between hepatocytes and hepatic stellate cells in liver fibrosis
by: Qihua Duan, et al.
Published: (2025-11-01)

MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression
by: Qi Wang, et al.
Published: (2020-06-01)

Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways
by: Feng J, et al.
Published: (2018-06-01)

Effect of curcumin on the proliferation and apoptosis of hepatic stellate cells
by: J.C. Shu, et al.
Published: (2009-12-01)

Assessing the Biological Markers of MiRNA-9 and 192 Expression Levels in Cervical Cancer
by: Shaian Tavakolian, et al.
Published: (2025-08-01)

Hepatic Stellate Cell-Immune Interactions in NASH
by: James K. Carter, et al.
Published: (2022-06-01)

Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
by: Yufei Yan, et al.
Published: (2021-08-01)

Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
by: Sheng Liqin, et al.
Published: (2025-08-01)

Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver DiseaseSummary
by: Leke Wiering, et al.
Published: (2023-01-01)

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
by: SUN Lijie, HAO Dandan
Published: (2024-01-01)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
by: Yuan-Quan Zhao, et al.
Published: (2023-04-01)

Insights into the impact of hepatitis B virus on hepatic stellate cell activation
by: Hongjuan You, et al.
Published: (2023-04-01)

Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway
by: Meiling Zhang, et al.
Published: (2024-11-01)

Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis
by: Archittapon Nokkeaw, et al.
Published: (2023-01-01)

Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway
by: Yu-Jung Heo, et al.
Published: (2022-04-01)

Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation
by: Fangqing Zhao, et al.
Published: (2025-07-01)

Advances on TGF-β/Smad signal pathway in hepatic fibrosis
by: Han Daoning, et al.
Published: (2021-09-01)

Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non‐alcoholic steatohepatitis (NASH)
by: Natsuko Hada, et al.
Published: (2023-06-01)

Extracellular Vesicular Transmission of miR-423-5p from HepG2 Cells Inhibits the Differentiation of Hepatic Stellate Cells
by: Michal Safran, et al.
Published: (2022-05-01)

Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells
by: Kavita Prasad, et al.
Published: (2024-10-01)

Xiaochaihutang Inhibits the Activation of Hepatic Stellate Cell Line T6 Through the Nrf2 Pathway
by: Rui Hu, et al.
Published: (2019-01-01)

Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
by: GONG Xiaoqian, et al.
Published: (2025-04-01)

Perilipin 5 Ameliorates Hepatic Stellate Cell Activation via SMAD2/3 and SNAIL Signaling Pathways and Suppresses STAT3 Activation
by: Rafael Cierpka, et al.
Published: (2021-08-01)

Activin A plays an essential role in migration and proliferation of hepatic stellate cells via Smad3 and calcium signaling
by: Wei Zhang, et al.
Published: (2024-09-01)

Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation
by: Harrison T. Muturi, et al.
Published: (2024-10-01)

Overexpression of Rictor protein and Rictor-H. pylori interaction has impact on tumor progression and prognosis in patients with gastric cancer
by: Fang Wang, et al.
Published: (2020-07-01)

The mTORC2 Component Rictor Is Required for Load‐Induced Bone Formation in Late‐Stage Skeletal Cells
by: Karl J Lewis, et al.
Published: (2020-07-01)

Recombinant protein EBI3 attenuates Clonorchis sinensis-induced liver fibrosis by inhibiting hepatic stellate cell activation in mice
by: Lei Zhao, et al.
Published: (2023-07-01)

Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-κB Signaling Pathway in Hepatic Stellate Cells
by: Yuan-Hsi Wang, et al.
Published: (2020-03-01)

The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis
by: Joeri eLambrecht, et al.
Published: (2015-07-01)